Growth and phenotypic characteristics of human nevus cells in culture. 1988

M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.

Nevus cells were isolated from the three cutaneous components, epidermis, basal layer, and dermis, of nonmalignant pigmented lesions and were cultured separately in the presence or absence of the phorbol ester 12-0-tetradecanoyl phorbol-13-acetate in medium that supports the rapid proliferation of melanocytic cells. The separation procedure used provided cultures that were essentially free from normal melanocytes (dermis) or fibroblasts (epidermis). In short term culture, nevus cells of all skin compartments expressed markers associated with differentiated melanocytes, such as presence of premelanosomes and melanosomes and elevated tyrosinase levels. Nevus cells also expressed melanoma-associated antigens, such as NGF-receptor, transferrin-related p97, proteoglycan, and HLA-DR as detected with monoclonal antibodies. After several subpassages, cells showed a decreased expression of melanoma-associated antigens, decreased tyrrosinase levels, and melanosomes could no longer be detected. Morphologically, these cells were similar to fibroblasts. The disappearance of melanoma-associated cell surface antigens was concomitant with the appearance of a melanocyte-associated 145 kd protein that might serve as a marker of fibroblast-like differentiation in nevus cells and normal melanocytes. Nevus cell cultures grown in the presence of 12-0-tetradecanoyl phorbol-13-acetate maintained a stable differentiated phenotype throughout their lifespan. As reported earlier, nevus cells in culture, irrespective of the presence or absence of 12-0-tetradecanoyl phorbol-13-acetate, have a finite lifespan in vitro, grow anchorage-independent in soft agar, but do not form tumors when xenografted to nude mice. These studies demonstrate that nevus cells isolated from the epidermal, basal layer, and dermal components of lesional skin can serve as models to characterize the initial steps of tumor progression in a human cell system.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009506 Nevus A circumscribed stable malformation of the skin and occasionally of the oral mucosa, which is not due to external causes and therefore presumed to be of hereditary origin. Mole, Skin,Moles, Skin,Skin Mole,Nevi,Skin Moles
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
April 2011, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
October 1979, Investigative ophthalmology & visual science,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
September 1981, Journal of neuropathology and experimental neurology,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
March 1979, Bulletin de l'Association des anatomistes,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
April 2007, Journal of cellular biochemistry,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
July 1986, The Journal of investigative dermatology,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
February 1984, In vitro,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
January 1985, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
July 1960, Cancer research,
M L Mancianti, and M Herlyn, and D Weil, and J Jambrosic, and U Rodeck, and D Becker, and L Diamond, and W H Clark, and H Koprowski
September 1960, Obstetrics and gynecology,
Copied contents to your clipboard!